Eli Lilly is releasing a cheaper version of its weight loss drug Zepbound.hit a new intraday record and closed at a record high on Monday. The 30-stock index closed up 65.44 points, or 0.16%, after rallying more than 200 points earlier in the day. Thedidn't fare as well, falling 0.32% and 0.85%, respectively. Traders appeared to be favoring other sectors in the market and rotating out of tech. And AI darlingclosed down 2.3% ahead of its earnings report due Wednesday afternoon.
The new form of the drug is roughly half of its usual monthly list price: Eli Lilly is now selling 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively, via its direct-to-consumer website. That compares with current list prices of roughly $1,000 per month before insurance and other rebates for Zepbound and other weight loss drugs, such as Novo Nordisk's Wegovy.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: NBCNewYork - 🏆 270. / 63 Read more »
Source: nbcchicago - 🏆 545. / 51 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: NBCDFW - 🏆 288. / 63 Read more »
Source: CNBC - 🏆 12. / 72 Read more »